Cargando…

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD

The effect of moderate alcohol consumption on NAFLD histology is disputed. Assessment of alcohol consumption is commonly performed with interview or questionnaires. Phosphatidylethanol (PEth) in blood is a highly sensitive and specific alcohol biomarker, which only forms in the presence of ethanol....

Descripción completa

Detalles Bibliográficos
Autores principales:	Blomdahl, Julia, Nasr, Patrik, Ekstedt, Mattias, Kechagias, Stergios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833449/ https://www.ncbi.nlm.nih.gov/pubmed/36633482 http://dx.doi.org/10.1097/HC9.0000000000000003

Ejemplares similares

Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017)

Repeated measurements of non‐invasive fibrosis tests to monitor the progression of non‐alcoholic fatty liver disease: A long‐term follow‐up study
por: Balkhed, Wile, et al.
Publicado: (2022)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

Natural history of nonalcoholic fatty liver disease: A prospective follow‐up study with serial biopsies
por: Nasr, Patrik, et al.
Publicado: (2017)

Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease
por: Gruneau, Lina, et al.
Publicado: (2023)

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
por: Shang, Ying, et al.
Publicado: (2020)

Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
por: Nasr, Patrik, et al.
Publicado: (2021)

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
por: Hagström, Hannes, et al.
Publicado: (2017)

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
por: Holmer, Magnus, et al.
Publicado: (2022)

Hepatic patatin‐like phospholipase domain‐containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans
por: Ericson, Elke, et al.
Publicado: (2022)

Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms
por: Lykiardopoulos, Byron, et al.
Publicado: (2016)

Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
por: Jarvis, Helen, et al.
Publicado: (2022)

Automated quantification of steatosis: agreement with stereological point counting
por: Homeyer, André, et al.
Publicado: (2017)

Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2020)

Coffee Consumption and the Progression of NAFLD: A Systematic Review
por: Sewter, Rebecca, et al.
Publicado: (2021)

Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
por: Polyzos, Stergios A., et al.
Publicado: (2020)

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
por: Lee, Giljae, et al.
Publicado: (2020)

Risk of cardiovascular disease and loss in life expectancy in NAFLD
por: Shang, Ying, et al.
Publicado: (2022)

A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones
por: Chou, Yu-Tsung, et al.
Publicado: (2021)

Moderate alcohol consumption and cognitive risk
por: Neafsey, Edward J, et al.
Publicado: (2011)

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
por: Lemmer, Peter, et al.
Publicado: (2022)

Comparison of the role of alcohol consumption and qualitative abdominal fat on NAFLD and MAFLD in males and females
por: Sogabe, Masahiro, et al.
Publicado: (2022)

Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression
por: Wang, Yuying, et al.
Publicado: (2021)

A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease
por: Lambrecht, Joeri, et al.
Publicado: (2019)

Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation?
por: Zakhari, Samir, et al.
Publicado: (2018)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

High Meat Consumption Is Prospectively Associated with the Risk of Non-Alcoholic Fatty Liver Disease and Presumed Significant Fibrosis
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2022)

Model-inferred mechanisms of liver function from magnetic resonance imaging data: Validation and variation across a clinically relevant cohort
por: Forsgren, Mikael F., et al.
Publicado: (2019)

The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease
por: Nobili, Valerio, et al.
Publicado: (2009)

NAFLD-Associated HCC: Progress and Opportunities
por: Geh, Daniel, et al.
Publicado: (2021)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

A continuous-time Markov chain model of fibrosis progression in NAFLD and NASH
por: Meyer, Lyndsey F., et al.
Publicado: (2023)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
por: Oh, Hyunwoo, et al.
Publicado: (2023)

Alcohol Consumption as a Moderator of Anxiety and Sleep Quality
por: CHUEH, Ke-Hsin, et al.
Publicado: (2019)

Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients?
por: Sohrabi, Masoudreza, et al.
Publicado: (2021)

Lipophagy Impairment Is Associated With Disease Progression in NAFLD
por: Carotti, Simone, et al.
Publicado: (2020)

Risk of severe illness of COVID‐19 patients with NAFLD and increased NAFLD fibrosis scores
por: Yao, Renling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0n7qg8q44blvf60ul75db5ks22